Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_assertion type Assertion NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_head.
- NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_assertion wasGeneratedBy ECO_0000203 NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_provenance.
- NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_assertion wasDerivedFrom befree-20150227 NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_provenance.
- NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_assertion SIO_000772 16435073 NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_provenance.
- NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_assertion evidence source_evidence_literature NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_provenance.
- NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_assertion description "[Further analysis of primary tumors indicated that the frequency of hypermethylation was high for ASC (82%) and PAX3 (86%) in all tumor types, and high for RIPK3 in small cell carcinoma (57%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859007.RAzFy-bCIqAQgVc4eyUcZNsawSaPl1gwiTNIutq1uK2vM130_provenance.